nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Microsimulation Model for Evaluating the Effectiveness of Cancer Risk Management for BRCA Pathogenic Variant Carriers: miBRovaCAre
|
Petelin, Lara |
|
2019 |
22 |
8 |
p. 854-862 |
artikel |
2 |
An Ethical Analysis of Coverage With Evidence Development
|
Carter, Drew |
|
2019 |
22 |
8 |
p. 878-883 |
artikel |
3 |
A Scoping Review of Investment Cases for Vaccines and Immunization Programs
|
Sim, So Yoon |
|
2019 |
22 |
8 |
p. 942-952 |
artikel |
4 |
Author Reply
|
Zimmermann, Marita |
|
2019 |
22 |
8 |
p. 972-973 |
artikel |
5 |
Copyright/Subscription
|
|
|
2019 |
22 |
8 |
p. iv |
artikel |
6 |
Cost-Effectiveness of Cryoballoon Ablation Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation in China: Results Based on Real-World Data
|
Ming, Jian |
|
2019 |
22 |
8 |
p. 863-870 |
artikel |
7 |
Editorial Board
|
|
|
2019 |
22 |
8 |
p. v |
artikel |
8 |
Implications of Nonmarginal Budgetary Impacts in Health Technology Assessment: A Conceptual Model
|
Howdon, Daniel D.H. |
|
2019 |
22 |
8 |
p. 891-897 |
artikel |
9 |
Important Considerations in Modeling the Cost-Effectiveness for the First Food and Drug Administration–Approved Gene Therapy and Implications for Future One-Time Therapies
|
Buessing, Marric |
|
2019 |
22 |
8 |
p. 970-971 |
artikel |
10 |
Incorporating Affordability Concerns Within Cost-Effectiveness Analysis for Health Technology Assessment
|
Lomas, James R.S. |
|
2019 |
22 |
8 |
p. 898-905 |
artikel |
11 |
Normative Profile of Health-Related Quality of Life for Hong Kong General Population Using Preference-Based Instrument EQ-5D-5L
|
Wong, Eliza Lai-yi |
|
2019 |
22 |
8 |
p. 916-924 |
artikel |
12 |
Patient-Reported Outcomes in Orphan Drug Labels Approved by the US Food and Drug Administration
|
Hong, Yoon Duk |
|
2019 |
22 |
8 |
p. 925-930 |
artikel |
13 |
Per-Prescription Drug Expenditure by Source of Payment and Income Level in the United States, 1997 to 2015
|
Tang, Wenxi |
|
2019 |
22 |
8 |
p. 871-877 |
artikel |
14 |
PROM Validation Using Paper-Based or Online Surveys: Data Collection Methods Affect the Sociodemographic and Health Profile of the Sample
|
Rowen, Donna |
|
2019 |
22 |
8 |
p. 845-850 |
artikel |
15 |
Selection of Endpoints in Clinical Trials: Trends in European Marketing Authorization Practice in Oncological Indications
|
Kordecka, Anna |
|
2019 |
22 |
8 |
p. 884-890 |
artikel |
16 |
Symptoms of Major Depressive Disorder Scale: Performance of a Novel Patient-Reported Symptom Measure
|
Bushnell, Donald M. |
|
2019 |
22 |
8 |
p. 906-915 |
artikel |
17 |
Table of Contents
|
|
|
2019 |
22 |
8 |
p. i-iii |
artikel |
18 |
United States Valuation of EQ-5D-5L Health States Using an International Protocol
|
Pickard, A. Simon |
|
2019 |
22 |
8 |
p. 931-941 |
artikel |
19 |
Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip Replacement: A Systematic Review and Network Meta-Analysis
|
Lewis, Sedina |
|
2019 |
22 |
8 |
p. 953-969 |
artikel |
20 |
When Opportunity Knocks, What Does It Say?
|
Phelps, Charles E. |
|
2019 |
22 |
8 |
p. 851-853 |
artikel |